1836
A.-Z. Andreou et al. / Phytochemistry 69 (2008) 1832–1837
C-13. This suggests that also in the case of DNt-NspLOX the sub-
strate orientation remains unaffected by the performed mutations
and the insertion of a bulkier amino acid (Val and Ile) possibly
shields the C-9 from the oxygen attack (Fig. 5).
150 mM NaCl, 10% (w/w) glycerol, 0.1% (v/v) Tween20). The cells
were disrupted by 2 pulses of 20 s of sonification on ice. 250 lg
of LA was added to a 900 ll aliquot of the crude extract and reac-
tions allowed to proceed for 30 min at room temperature. Hydro-
peroxides formed were reduced to their corresponding
hydroxides with 900 ll of 50 mM SnCl2, dissolved in methanol.
After acidification to pH 3.0 with glacial acetic acid, fatty acids
were extracted as described (Bligh and Dyer, 1959).
However, the low sequence similarity of DNt-NspLOX with
LOXs which have elucidated structures such as LOX-1 and LOX-3
from soybean does not allow modelling of the protein and there-
fore does not allow prediction of the location of the oxygen chan-
nel. Moreover DNt-NspLOX has a large deletion in the protein
sequence, which possibly renders the active site pocket of the pro-
tein different then the majority of LOXs (Lang et al., 2008). It can be
assumed that in the case of DNt-NspLOX the space in the active site
pocket of DNt-NspLOX is larger, since the presence of an Ala in the
position of the ‘‘Coffa site” does not inhibit oxygenation at the C-9.
Additionally the replacement of Ala by significantly more space
filling amino acids such as Val or an Ile can be accommodated
and still yields catalytically active enzymes.
In summary, what can be implied by our results and the com-
parison with previous studies on the stereospecificity of LOXs is
that the residue aligning with a conserved Ala in the case of S-LOXs
and a conserved Gly in R-LOXs is crucial in determining the stereo-
specificity of the product. However, the presence of a Gly vs. an Ala
in the primary structure of a LOX is not sufficient to determine
whether the enzyme is R or S specific, but the morphology and size
of the active site also plays a determining role.
After removing the organic solvent, the residue was reconsti-
tuted in 80 ll of methanol/water/acetic acid (85:15:0.1, v/v) and
subjected to HPLC analysis. HPLC analysis was performed with an
Agilent 1100 HPLC system (Waldbronn) coupled to a diode array
detector. Hydroxy fatty acids were separated from fatty acids by
reversed phase HPLC (RP-HPLC; EC250/4 Nucleosil 120-5 C18,
Macherey-Nagel) eluted with a solvent system of: solvent A, meth-
anol/water/acetic acid (85:15:0.1, v/v) and solvent B, methanol/
acetic acid (100:0.1, v/v) at a flow rate of 0.18 ml/min. Straight
phase HPLC (SP-HPLC) of hydroxy fatty acid isomers was carried
out on a Zorbax SIL column (250/4.6, 5 lm particle size, Agilent)
eluted with a solvent system of hexane/2-propanol/acetic acid
(100:1:0.1, v/v) at a flow rate of 0.2 ml/min. CP-HPLC of the hydro-
xy fatty acids was carried out on a Chiralcel OD-H column
(2.1 ꢀ 150 mm, 5-lm particle size, Daicel, distributed by VWR)
with
a solvent system of n-hexane/2-propanol/acetic acid
(100:5:0.1, v/v) and a flow rate of 0.1 ml/min. The absorbance at
234 nm (conjugated diene system of the hydroxy fatty acids) was
recorded simultaneously during all chromatographic steps.
The activity of DNt-NspLOX using PC as substrate was measured
by incubating 0.7 nmol purified protein with 0.6 mg 1,2 Dilinoleyl-
sn-Glycero-3-Phosphocholine (Avanti Polar Lipids) in 5 ml buffer
(50 mM Tris pH 7.5, 4 mM sodium deoxycholate) under constant
stirring for 30 min at room temperature. Reduction of the hydro-
peroxides was performed as described above. The lipid bound fatty
acids were the converted to the corresponding methyl esters by
adding 500 ll of 1% sodium methoxide solution to the dried after
chloroform evaporation samples and shaking for 20 min at room
temperature. 500 ll 6 M NaCl was added to the reaction and the
methyl esters were then extracted twice with 750 ll hexane. The
solvent was removed by evaporation under streaming nitrogen
and the sample was dissolved in 80 ll of methanol/water/acetic
acid (85:15:0.1, v/v/v). Methyl esters were separated by reversed
phase-HPLC (RP-HPLC) with a solvent system of methanol/water/
acetic acid (75:25:0.1 v/v) at a flow rate of 0.18 ml/min. Straight
phase-HPLC (SP-HPLC) analysis was carried out with a solvent sys-
tem hexane: 2-propanol: trifluoroacetic acid (100:1:0.02, v/v/v) at
a flow rate of 0.1 ml/min.
Note: While this manuscript was under revision another paper
describing a similar set of experiments was published (Zheng et al.,
2008).
4. Experimental
4.1. Site-directed mutagenesis
Construction of mutants of the DNt-NspLOX domain of NspLOX
were performed using the QuikChange site-directed mutagenesis
kit (Stratagene). The overlapping mismatching primers used were
NspLOXA162GF 50-TTATCAACTCATCAGGTGTTCCAAAGATTATC-30;
NspLOXA162GR 50-GATAATCTTTGGAACACCTGATGAGTTGATAA-30,
NspLOXA162VF 50-TTATCAACTCATCAGTTGTTCCAAAGATTATC-30,
NspLOXA162VR 50-GATAATCTTTGGAACAACTGATGAGTTGATAA-30,
NspLOXA162IF
50-TTATCAACTCATCAATTGTTCCAAAGATTATC-30
and NspLOXA162R 50-GATAATCTTTGGAACAATTGATGAGTTGAT-
AA-30. The His-tagged DNt-NspLOX domain in the pET15b expres-
sion vector was used as template (Lang et al., 2008). The desired
mutations were confirmed by sequencing.
4.2. Overexpression and protein purification
4.4. Steady-state kinetic measurements
Expression of the protein was performed in E. coli BL21 Star
(DE3) cells. The cultures were grown at 37 °C until OD600 0.6, in-
duced with 0.1 mM IPTG and further incubated for 48 h at 16 °C.
For purification of DNt-NspLOX frozen cell pellets were lysed using
BPer (Pierce) according to manufacturer’s instructions. Cell debris
was removed by centrifugation at 27,000g for 20 min at 4 °C and
supernatant was applied to a 1 ml HisTrap FF column (GE Health-
care) previously equilibrated with 50 mM Tris pH 7.5. The column
was then washed with 50 mM Tris pH 7.5, 300 mM NaCl, 10 mM
imidazole and protein was eluted with 50 mM Tris pH 7:5,
300 mM NaCl, 200 mM imidazole. DNt-NspLOX was further puri-
fied using the Superdex 200 HR (GE Healthcare).
KM and vmax were determined by monitoring the formation of
the conjugated double bond of the product at 234 nm
(e = 2.5 ꢀ 104 Mꢁ1 cmꢁ1) with CARY 100 Bio (Varian). The assay
samples were 1 ml in volume and substrate concentrations were
3–100 lM (Borate buffer, pH 7.5). Linear parts of the curves were
used for Dixon plot.
Acknowledgements
The authors are grateful to Theres Riemekasten, Göttingen, for
excellent technical assistance and Dr. Cornelia Göbel, Göttingen,
for continuous support and stimulating discussions. A.A. is
supported by the International Max Planck Research School
Molecular Biology (Goettingen) and the project is funded by IRTG
1422 Metal Sites in Biomolecules: Structures, Regulation and
Mechanisms.
4.3. LOX activity assay
For activity assays the pellets of 30 ml expression cultures of E.
coli cells were resuspended in 5 ml lysis buffer (50 mM Tris, pH 8.0,